LPTX Leap Therapeutics Inc

Leap Therapeutics Inc is a biopharmaceutical company . The Company is engaged in acquiring and developing novel therapeutics at the leading edge of cancer biology.

As of 05/24/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/25/2017
Outstanding shares:  88,318,454
Average volume:  879,398
Market cap:   $103,332,591
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYNS707
Valuation   (See tab for details)
PE ratio:   -3.20
PB ratio:   1.02
PS ratio:   137.71
Return on equity:   -42.44%
Net income %:   -5,574.41%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy